Alpharetta, Georgia — According to state and local development sources, Neuragenex plans to build out 4,061 square feet of new space in Alpharetta. The company plans to occupy the new space at 5315 Flynn Xing in Alpharetta, on or about June 1, 2024. According to the company website Neuragenex was founded as a next-generation chronic pain management program, offering a better way to manage chronic pain that not only relieves pain, but improves health and results in an enhanced and magnified quality of life. Neuragenex is a non-pharmaceutical, non-surgical, non-invasive, and non-chiropractic pain treatment program. As the nations fastest growing chronic pain treatment practice, our mission is to relieve pain, restore health, and magnify quality of life without drugs, surgery, or invasive procedures. Neuragenex has successfully treated thousands of chronic pain patients, many of which had no idea that an option like Neuragenex was available. Given the choice, patients will choose the least-invasive, most-effective, and longest-lasting treatment option available. This means that given the choice, patients will choose Neuragenex first over other conventional treatments like medications, surgeries, or invasive procedures and implants. Our vision is to be the first thought, first choice, and first step in the journey of chronic pain relief.

To learn more about Neuragenex, visit http://neuragenex.com/

Company Contact:
William Bozeman, Chief Executive Officer
https://www.linkedin.com/in/william-bozeman-1b715a103/
888-912-5037

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.